level-one heading

Kolabtreeを選ぶ理由
開始はすばやく簡単です。初期費用はかかりません。
サービス依頼と専門家への見積依頼は無料です。
Kolabtree の作業範囲に同意する前に、専門家と要件を詳しく相談できます。
専門家と直接連携し、必要な成果を正しく得られます。
専門家を採用したらプロジェクトに資金を入れ、作業完了後に成果物を承認できます。
この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
プロジェクトを作成
★★★★★
☆☆☆☆☆
Dr. Gamal Eldein Fathy Abd-Ellatef A.に依頼
Egypt

I am a Researcher in National Research Center in Egypt in Cancer Biology and Molecular Physiology research fields.

プロフィール概要
専門分野
サービス
Writing Technical Writing
Research Market Research, User Research, Meta-Research, Gap Analysis, Gray Literature Search, Systematic Literature Review
職務経験

Researcher, Dr.

National Research Centre

12月 2020 - 現在

Assistant Researcher

National Research Centre

3月 2013 - 12月 2020

Researcher Assistant

National Research Centre

6月 2006 - 3月 2013

学歴

Ph.D. in Integrated Molecular Physiology (Faculty of Science)

Cairo University

10月 2015 - 8月 2020

Ph.D in Molecular Medicine (Oncology Department)

Università degli Studi di Torino Dipartimento di Oncologia

9月 2016 - 4月 2020

認定資格
  • 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
Gamal-Eldein Fathy Abd-Ellatef, Elena Gazzano, Daniela Chirio, Ahmed Ragab Hamed, Dimas Carolina Belisario, Carlo Zuddas, Elena Peira, Barbara Rolando, Joanna Kopecka, Mohamed Assem Said Marie, et al.(2020). Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells . Pharmaceutics. 12. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 96. {MDPI} {AG}
Abd-Ellatef, G.-E.F., Gazzano, E., Chirio, D., Hamed, A.R., Belisario, D.C., Zuddas, C., Peira, E., Rolando, B., Kopecka, J., Marie, M.A.S., et al.(2020). Curcumin-loaded solid lipid nanoparticles bypass p-glycoprotein mediated doxorubicin resistance in triple negative breast cancer cells . Pharmaceutics. 12. (2).
Salaroglio IC, Gazzano E, Abdullrahman A, Mungo E, Castella B, Abd-Elrahman GEFA, Massaia M, Donadelli M, Rubinstein M, Riganti C, et al.(2018). Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer . Journal of experimental & clinical cancer research : CR.
Ahmed R. Hamed and Mohamed Emara and Maha M. Soltan and Shaymaa M. M. Yahya and Heba K. Nabih and Ghada H. Elsayed(2018). Investigating the role of miRNA-98 and miRNA-214 in chemoresistance of HepG2/Dox cells: studying their effects on predicted ABC transporters targets . Medicinal Chemistry Research. 27. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 531--537. Springer Science and Business Media {LLC}
Salaroglio, I.C., Gazzano, E., Abdullrahman, A., Mungo, E., Castella, B., Abd-Elrahman, G.E.F.A.-E., Massaia, M., Donadelli, M., Rubinstein, M., Riganti, C., et al.(2018). Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer . Journal of Experimental and Clinical Cancer Research. 37. (1).
Chegaev, K., Fraix, A., Gazzano, E., Abd-Ellatef, G.E.F., Blangetti, M., Rolando, B., Conoci, S., Riganti, C., Fruttero, R., Gasco, A., et al.(2017). Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance . ACS Medicinal Chemistry Letters. 8. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 361-365.
Abd-Ellatef, G.-E.F., Ahmed, O.M., Abdel-Reheim, E.S., Abdel-Hamid, A.-H.Z.(2017). Ulva lactuca polysaccharides prevent Wistar rat breast carcinogenesis through the augmentation of apoptosis, enhancement of antioxidant defense system, and suppression of inflammation . Breast Cancer: Targets and Therapy. 9. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 67-83.
El-Kashak, W.A., Hamed, A.R., El-Raey, M., Elshamy, A.I., Abd-Ellatef, G.E.F.(2016). Antiproliferative, antioxidant and antimicrobial activities of phenolic compounds from Acrocarpus fraxinifolius . Journal of Chemical and Pharmaceutical Research. 8. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 520-528.
Yahya, S.M.M., Hamed, A.R., Emara, M., Soltan, M.M., Abd-Ellatef, G.E.F., Abdelnasser, S.M.(2016). Differential effects of c-myc and ABCB1 silencing on reversing drug resistance in HepG2/Dox cells . Tumor Biology. 37. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 5925-5932.